Menu

  • Transcatheter Aortic Valve Implantation
  • Procedure & Performance
  • Clinical Evidence
  • Education & Resources
  • Treating ssAS

    • The problem

    350,000

    people in Western Europe develop annually symptomatic severe aortic stenosis (SSAS).1–9

    48%

    of those patients are undertreated nationally.1–10

    More than 120,000

    remain untreated.8

    Women are
    up to 35%

    less likely than men to be treated for aortic valve implantation (AVI).11

    Medical management isn’t enough.

    If left untreated, average patient survival is just 50% at two years.12

     

    Symptomatic severe aortic stenosis can be fatal.

    Aortic stenosis is among the most common of all valvular heart diseases and continues to increase as our population ages.13 ssAS can be fatal if left untreated.

    Once symptoms begin, survival is cut short.12

    Aortic valve implantation greatly improves the rate of survival.

    “Mortality difference for people with symptoms of aortic stenosis treated with aortic valve replacement versus those not undergoing this procedure is one of the most striking in medicine.“13

    For women, the difference in survival is even starker.

     

    If women do receive treatment, they have a lower mortality rate,14 excellent outcomes compared to SAVR,15 and superior valve performance to the SAPIEN™* platform.16

    Patients with ssAS: operated versus unoperated ssAS survival rates13,17

    Urgency is everything for ssAS patients.

    Detect the murmur.

    You can help save more lives by recognizing the symptoms of ssAS early on.

    Remember to:

    1. Listen for the murmur.
    2. Order an echocardiogram.
    3. Refer patients to a heart valve team without delay.

    Learn about determining the severity of aortic stenosis and when to refer patients to the heart team.

    Experts share their experiences assessing and treating patients with severe aortic stenosis.

    Refer your ssAS patients to the heart valve team.

    Follow updated ESC/EACTS guidelines.

    “Class 1B recommendation for intervention: Patients with symptomatic severe high-gradient aortic stenosis, low-flow, low-gradient aortic stenosis with reduced ejection fraction, AND evidence of flow reserve. Class 1B and 1C recommendation for intervention: Expanded to asymptomatic severe aortic stenosis patients, considering a careful heart team evaluation of their treatment need."*

    Understanding severe symptomatic aortic stenosis from a patient point of view

    90%

    of patients with heart valve disease are influenced by conversations with their doctor when making ssAS treatment decisions.18

    Additional information

    Inquiries about referring patients or becoming a study site?

    Email us

    Connect with us on social.

    LinkedIn: Medtronic Cardiac and Vascular